Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation-Reference-Cited by-同舟云学术

Validation of biomarkers to predict response to immunotherapy in cancer: Volume I — pre-analytical and analytical validation

Published:2016-11-15 Issue:1 Volume:4 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Masucci Giuseppe V.,Cesano Alessandra,Hawtin Rachael,Janetzki Sylvia,Zhang Jenny,Kirsch Ilan,Dobbin Kevin K.,Alvarez John,Robbins Paul B.,Selvan Senthamil R.,Streicher Howard Z.,Butterfield Lisa H.,Thurin Magdalena

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-016-0178-1.pdf

Reference182 articles.

1. Pardoll DM. Immunology beats cancer: a blueprint for successful translation. Nat Immunol. 2012;13(12):1129–32. doi: 10.1038/ni.2392 .

2. Hodi FS, O’Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711–23. doi: 10.1056/NEJMoa1003466 .

3. Robert C, Thomas L, Bondarenko I, O’Day S, Weber J, Garbe C, et al. Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med. 2011;364(26):2517–26. doi: 10.1056/NEJMoa1104621 .

4. Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443–54. doi: 10.1056/NEJMoa1200690 .

5. Motzer RJ, Rini BI, McDermott DF, Redman BG, Kuzel TM, Harrison MR, et al. Nivolumab for metastatic renal cell carcinoma: results of a randomized phase II trial. J Clin Oncol. 2015;33(13):1430–7. doi: 10.1200/jco.2014.59.0703 .

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential prognostic predictors of treatment with immune checkpoint inhibitors for advanced endometrial cancer;Japanese Journal of Clinical Oncology;2024-09-03

2. Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours;Clinical and Translational Medicine;2024-08

3. Personalized metabolic whole-body models for newborns and infants predict growth and biomarkers of inherited metabolic diseases;Cell Metabolism;2024-08

4. Stimulator of interferon genes mediated immune senescence reveals the immune microenvironment and prognostic characteristics of bladder cancer;Heliyon;2024-05

5. Current evidence of PD-1 and PD-L1 immune checkpoint inhibitors for esophageal cancer: an updated meta-analysis and synthesis of ongoing clinical trials;Therapeutic Advances in Medical Oncology;2024-01